Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 19 | 2023 | 169 | 4.000 |
Why?
|
| Pneumococcal Infections | 4 | 2023 | 27 | 1.580 |
Why?
|
| Bacteremia | 3 | 2010 | 31 | 0.930 |
Why?
|
| Child | 20 | 2023 | 2875 | 0.800 |
Why?
|
| Mass Casualty Incidents | 1 | 2020 | 2 | 0.790 |
Why?
|
| Physician's Role | 1 | 2020 | 34 | 0.770 |
Why?
|
| Stroke | 4 | 2015 | 274 | 0.630 |
Why?
|
| Cord Blood Stem Cell Transplantation | 2 | 2006 | 3 | 0.540 |
Why?
|
| Databases, Factual | 1 | 2015 | 288 | 0.490 |
Why?
|
| Brain Ischemia | 1 | 2015 | 179 | 0.460 |
Why?
|
| Bacteriological Techniques | 2 | 2010 | 13 | 0.430 |
Why?
|
| Child, Preschool | 11 | 2015 | 1318 | 0.430 |
Why?
|
| Hemoglobin, Sickle | 3 | 2023 | 13 | 0.400 |
Why?
|
| Pneumococcal Vaccines | 2 | 2008 | 13 | 0.390 |
Why?
|
| Blood Specimen Collection | 1 | 2010 | 12 | 0.380 |
Why?
|
| Iron Overload | 1 | 2009 | 7 | 0.360 |
Why?
|
| Graft vs Host Disease | 3 | 2009 | 15 | 0.350 |
Why?
|
| Liver Cirrhosis | 1 | 2009 | 51 | 0.350 |
Why?
|
| Ferritins | 1 | 2009 | 54 | 0.340 |
Why?
|
| Immunity, Herd | 1 | 2008 | 2 | 0.330 |
Why?
|
| Meningococcal Vaccines | 1 | 2008 | 7 | 0.330 |
Why?
|
| Vaccination | 2 | 2021 | 259 | 0.320 |
Why?
|
| Humans | 30 | 2023 | 34853 | 0.320 |
Why?
|
| Histocompatibility Testing | 2 | 2009 | 7 | 0.310 |
Why?
|
| Fetal Blood | 1 | 2007 | 47 | 0.310 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2006 | 3 | 0.280 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2009 | 47 | 0.270 |
Why?
|
| Infant | 6 | 2015 | 1014 | 0.270 |
Why?
|
| Vaccines, Conjugate | 1 | 2023 | 7 | 0.240 |
Why?
|
| Penicillins | 1 | 2003 | 12 | 0.240 |
Why?
|
| Bone Marrow Transplantation | 3 | 2009 | 15 | 0.220 |
Why?
|
| beta-Thalassemia | 2 | 1998 | 7 | 0.210 |
Why?
|
| Acute Chest Syndrome | 1 | 2021 | 2 | 0.210 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 50 | 0.200 |
Why?
|
| Influenza, Human | 1 | 2021 | 79 | 0.190 |
Why?
|
| Commerce | 1 | 2020 | 81 | 0.180 |
Why?
|
| Catheterization, Central Venous | 1 | 1999 | 6 | 0.180 |
Why?
|
| Follow-Up Studies | 7 | 2009 | 964 | 0.180 |
Why?
|
| Opportunistic Infections | 1 | 1999 | 10 | 0.180 |
Why?
|
| Blood | 1 | 1999 | 32 | 0.180 |
Why?
|
| Yersinia Infections | 1 | 1998 | 2 | 0.170 |
Why?
|
| Yersinia enterocolitica | 1 | 1998 | 2 | 0.170 |
Why?
|
| Male | 16 | 2015 | 18870 | 0.170 |
Why?
|
| Female | 16 | 2015 | 19873 | 0.170 |
Why?
|
| Bronchitis | 1 | 1997 | 5 | 0.160 |
Why?
|
| Dyspnea | 1 | 1997 | 15 | 0.160 |
Why?
|
| Lectins | 2 | 1994 | 20 | 0.150 |
Why?
|
| Chest Pain | 1 | 1997 | 36 | 0.150 |
Why?
|
| Adolescent | 7 | 2015 | 5035 | 0.150 |
Why?
|
| Killer Cells, Natural | 2 | 1994 | 86 | 0.140 |
Why?
|
| Hemoglobin C | 1 | 2015 | 1 | 0.140 |
Why?
|
| Bacteria | 1 | 1999 | 245 | 0.140 |
Why?
|
| Neonatal Screening | 1 | 2015 | 26 | 0.140 |
Why?
|
| Transplantation Chimera | 3 | 2009 | 7 | 0.140 |
Why?
|
| Gene Frequency | 1 | 2015 | 155 | 0.130 |
Why?
|
| HLA-DR Antigens | 2 | 2006 | 20 | 0.130 |
Why?
|
| Deferoxamine | 2 | 2009 | 19 | 0.130 |
Why?
|
| Patient Discharge | 1 | 2015 | 92 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2015 | 1961 | 0.130 |
Why?
|
| Antigens, Differentiation | 1 | 1994 | 24 | 0.120 |
Why?
|
| Risk Factors | 4 | 2006 | 3414 | 0.120 |
Why?
|
| Umbilicus | 1 | 1993 | 4 | 0.120 |
Why?
|
| Clostridium Infections | 1 | 1993 | 5 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 1994 | 135 | 0.120 |
Why?
|
| Shock, Septic | 1 | 1993 | 16 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2012 | 12 | 0.110 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2012 | 31 | 0.110 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2012 | 58 | 0.110 |
Why?
|
| Incidence | 2 | 2008 | 882 | 0.100 |
Why?
|
| Democratic Republic of the Congo | 1 | 2010 | 5 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2012 | 528 | 0.100 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 165 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2009 | 322 | 0.100 |
Why?
|
| Malaria, Falciparum | 1 | 2011 | 81 | 0.090 |
Why?
|
| United States | 2 | 2021 | 3894 | 0.090 |
Why?
|
| Cost of Illness | 1 | 2010 | 79 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2561 | 0.090 |
Why?
|
| Gonadal Disorders | 1 | 2009 | 1 | 0.090 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2009 | 2 | 0.090 |
Why?
|
| Siderophores | 1 | 2009 | 9 | 0.090 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 26 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2009 | 91 | 0.090 |
Why?
|
| Central Nervous System Diseases | 1 | 2009 | 27 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 2 | 2010 | 355 | 0.090 |
Why?
|
| Georgia | 2 | 2008 | 155 | 0.090 |
Why?
|
| ROC Curve | 1 | 2009 | 138 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 528 | 0.080 |
Why?
|
| Immunization Schedule | 1 | 2008 | 7 | 0.080 |
Why?
|
| Fever | 2 | 1999 | 57 | 0.080 |
Why?
|
| Probability | 1 | 2008 | 75 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2008 | 727 | 0.080 |
Why?
|
| Serotyping | 2 | 2006 | 36 | 0.080 |
Why?
|
| Age Factors | 2 | 2008 | 1007 | 0.080 |
Why?
|
| Growth | 1 | 2007 | 12 | 0.080 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 2006 | 3 | 0.080 |
Why?
|
| Virginiamycin | 1 | 2006 | 1 | 0.080 |
Why?
|
| Tissue Donors | 2 | 2004 | 43 | 0.070 |
Why?
|
| Liver | 1 | 2009 | 447 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 423 | 0.070 |
Why?
|
| Streptococcus pneumoniae | 1 | 2006 | 28 | 0.070 |
Why?
|
| Health Status | 1 | 2009 | 356 | 0.070 |
Why?
|
| Registries | 1 | 2008 | 330 | 0.070 |
Why?
|
| HLA-A Antigens | 1 | 2004 | 7 | 0.060 |
Why?
|
| HLA-B Antigens | 1 | 2004 | 11 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2004 | 35 | 0.060 |
Why?
|
| Graft Rejection | 1 | 2004 | 38 | 0.060 |
Why?
|
| Osteosarcoma | 1 | 1982 | 24 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 1982 | 42 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2015 | 871 | 0.050 |
Why?
|
| Ketorolac Tromethamine | 1 | 2001 | 2 | 0.050 |
Why?
|
| Genotype | 2 | 2015 | 641 | 0.050 |
Why?
|
| Comorbidity | 1 | 2003 | 606 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2001 | 30 | 0.050 |
Why?
|
| Medicaid | 1 | 2021 | 102 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 112 | 0.050 |
Why?
|
| Neutropenia | 1 | 1999 | 18 | 0.040 |
Why?
|
| Causality | 1 | 1998 | 45 | 0.040 |
Why?
|
| Hemoglobin H | 1 | 1998 | 2 | 0.040 |
Why?
|
| Globins | 1 | 1998 | 9 | 0.040 |
Why?
|
| Canada | 1 | 1998 | 121 | 0.040 |
Why?
|
| Chelating Agents | 1 | 1998 | 53 | 0.040 |
Why?
|
| Hospitalization | 1 | 2021 | 370 | 0.040 |
Why?
|
| Point Mutation | 1 | 1998 | 88 | 0.040 |
Why?
|
| Pain | 1 | 2001 | 249 | 0.040 |
Why?
|
| Bronchoscopy | 1 | 1997 | 6 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2012 | 1353 | 0.040 |
Why?
|
| Cough | 1 | 1997 | 17 | 0.040 |
Why?
|
| Syndrome | 1 | 1997 | 72 | 0.040 |
Why?
|
| Acute Disease | 1 | 1997 | 141 | 0.040 |
Why?
|
| von Willebrand Diseases | 1 | 1996 | 2 | 0.040 |
Why?
|
| Factor VIII | 1 | 1996 | 11 | 0.040 |
Why?
|
| Middle East | 1 | 2015 | 18 | 0.040 |
Why?
|
| Graft Survival | 2 | 2009 | 34 | 0.030 |
Why?
|
| Africa | 1 | 2015 | 62 | 0.030 |
Why?
|
| Adult | 3 | 2021 | 11034 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1998 | 1490 | 0.030 |
Why?
|
| Cohort Studies | 1 | 1998 | 1422 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 358 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 249 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2015 | 328 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 9 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 63 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 71 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2009 | 1349 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2011 | 118 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1994 | 1124 | 0.020 |
Why?
|
| Plasmodium falciparum | 1 | 2011 | 121 | 0.020 |
Why?
|
| Donor Selection | 1 | 2009 | 7 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 179 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2009 | 19 | 0.020 |
Why?
|
| Siblings | 1 | 2009 | 16 | 0.020 |
Why?
|
| Neoplasms | 1 | 1999 | 1033 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1993 | 486 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 569 | 0.020 |
Why?
|
| Inflammation | 1 | 1993 | 577 | 0.020 |
Why?
|
| Antisickling Agents | 1 | 2007 | 15 | 0.020 |
Why?
|
| Erythromycin | 1 | 2006 | 14 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 2007 | 34 | 0.020 |
Why?
|
| Clindamycin | 1 | 2006 | 12 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2006 | 26 | 0.020 |
Why?
|
| Body Height | 1 | 2007 | 52 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 114 | 0.020 |
Why?
|
| Recurrence | 1 | 2006 | 125 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2006 | 78 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2006 | 203 | 0.020 |
Why?
|
| Weight Gain | 1 | 2007 | 128 | 0.020 |
Why?
|
| Time Factors | 2 | 2006 | 1681 | 0.020 |
Why?
|
| Phylogeny | 1 | 2006 | 612 | 0.010 |
Why?
|
| Femoral Neck Fractures | 1 | 1983 | 2 | 0.010 |
Why?
|
| Bone Screws | 1 | 1983 | 7 | 0.010 |
Why?
|
| Fracture Fixation, Internal | 1 | 1983 | 7 | 0.010 |
Why?
|
| Aging | 1 | 2007 | 639 | 0.010 |
Why?
|
| Emergencies | 1 | 2001 | 23 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 48 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1982 | 133 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 2001 | 2 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2001 | 59 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2001 | 101 | 0.010 |
Why?
|
| Patient Selection | 1 | 2001 | 154 | 0.010 |
Why?
|
| Prognosis | 1 | 1982 | 707 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 178 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 608 | 0.010 |
Why?
|
| Vietnam | 1 | 1998 | 38 | 0.010 |
Why?
|
| Codon | 1 | 1998 | 38 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1982 | 336 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 430 | 0.010 |
Why?
|
| Hemophilia A | 1 | 1996 | 4 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 1996 | 9 | 0.010 |
Why?
|
| Base Sequence | 1 | 1998 | 932 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 485 | 0.010 |
Why?
|
| Bony Callus | 1 | 1983 | 1 | 0.000 |
Why?
|
| Animals | 1 | 1993 | 14307 | 0.000 |
Why?
|
| Aged | 1 | 1983 | 6448 | 0.000 |
Why?
|
| Middle Aged | 1 | 1983 | 9642 | 0.000 |
Why?
|